European Journal of Dermatology

, Volume 24, Issue 2, pp 260–261 | Cite as

Disseminated porokeratosis transiently healed by cancer chemotherapy

  • Anne Laure Breton
  • Pauline Pralong
  • Véronique Trillet-Lenoir
  • Brigitte Balme
  • Jean-François Nicolas
  • Frédéric Berard
Correspondence
  • 28 Downloads

Keywords

Paclitaxel Amyloidosis Cholangiocarcinoma Keratosis Advanced Squamous Cell Carcinoma 

References

  1. 1.
    Kanitakis J, Euvrard S, Faure M, Claudy A. Porokeratosis and immunosuppression. Eur J Dermatol 1998; 8: 459–465.PubMedGoogle Scholar
  2. 2.
    Marque M, Meunier L. Porokeratosis. Ann Dermatol Venereol 2012; 139: 668–676.PubMedCrossRefGoogle Scholar
  3. 3.
    Lee H-W, Oh S-H, Choi J-C, et al. Disseminated superficial porokeratosis in a patient with cholangiocarcinoma. J Am Acad Dermatol 2006; 54(2 Suppl): S56–S58.PubMedCrossRefGoogle Scholar
  4. 4.
    Torres T, Velho GC, Selores M. Disseminated superficial porokeratosis in a patient with cholangiocarcinoma: a paraneoplastic manifestation? An Bras Dermatol 2010; 85: 229–231.PubMedCrossRefGoogle Scholar
  5. 5.
    Cannavó SP, Borgia F, Adamo B, Guarneri B. Simultaneous development and parallel course of disseminated superficial porokeratosis and ovarian cancer: Coincidental association or true paraneoplastic syndrome? J Am Acad Dermatol 2008; 58: 657–660.PubMedCrossRefGoogle Scholar
  6. 6.
    Kono T, Kobayashi H, Ishii M, Nishiguchi S, Taniguchi S. Synchronous development of disseminated superficial porokeratosis and hepatitis C virus-related hepatocellular carcinoma. J Am Acad Dermatol 2000; 43(5 Pt 2): 966–968.PubMedCrossRefGoogle Scholar
  7. 7.
    Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001; 357: 96–100.PubMedCrossRefGoogle Scholar
  8. 8.
    Magee JW, McCalmont TH, LeBoit PE. Overexpression of p53 tumor suppressor protein in porokeratosis. Arch Dermatol 1994; 130: 187–190.PubMedCrossRefGoogle Scholar
  9. 9.
    Arnold SM, Regine WF, Ahmed MM, et al. Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm. Int J Radiat Oncol Biol Phys 2004; 58: 1411–1417.PubMedCrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2014

Authors and Affiliations

  • Anne Laure Breton
    • 1
  • Pauline Pralong
    • 1
  • Véronique Trillet-Lenoir
    • 2
  • Brigitte Balme
    • 3
  • Jean-François Nicolas
    • 4
  • Frédéric Berard
    • 4
  1. 1.Allergology and Clinical Immunology DepartmentLyon-Sud University HospitalPierre-Bénite cedexFrance
  2. 2.Medical Oncology Department, UMR 3738Lyon-Sud University HospitalPierre-Bénite cedexFrance
  3. 3.Histopathology LaboratoryLyon-Sud University HospitalPierre-Bénite cedexFrance
  4. 4.Allergology and Clinical Immunology Department, INSERM U 1111-CIRILyon-Sud University HospitalPierre-Bénite cedexFrance

Personalised recommendations